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SUMMARY 
The conditions for maximal  activity of ethanolamine phosphokinase from rat  
liver were determined. All of the activity was located in the supernatant fraction after 
centrifugation at Ioo ooo X g for 6o min. The enzyme activity had a pH opt imum at 
8.5 and an apparent I(m for ethanolamine of I ,  IO 4 M at an ATP and Mg 2+ concentra- 
tion of 3.o mM. The enzyme uses the Mg-ATP complex as substrate and is inhibited 
by free ATP. Choline inhibits ethanolamine phosphokinase. Maximal inhibition is ob- 
tained at choline concentrations of o. 4 mM. Treatment  of the supernatant with 
Sephadex G-25 or by dialysis causes an increase in the maximal amount of inhibition 
obtained with choline. The inhibition by choline is non-competitive with ethanol- 
amine and competitive with ATP. Ethanolamine phosphokinase is inhibited by N,N-  
dimethylethanolamine and N-methylethanolamine but not by betaine, phosphoryl 
choline, CDP-choline or phosphorylethanolamine. 
The activity of ethanolamine phosphokinase is low in - -5-day fetal liver. The 
activity increases from --5 days to --2 days and drops at I day after birth. An 
endogenous inhibitor of ethanolamine phosphokinase is present in all preparations 
but at different levels. The drop in activity in 1-day-old animals is due to the presence 
of higher amounts of inhibition by the endogenous inhibitor within the preparation. 
Evidence indicates that  the endogenous inhibitor is choline. 
INTRODUCTION 
Ethanolamine phosphokinase catalyzes the formation of phosphorylethanol- 
amine from ATP and ethanolamine. This is the initial reaction in the pathway for 
the de novo synthesis of ethanolamine phosphoglycerides 1. The occurrence of such a 
reaction was first suggested by studies on the incorporation by brain minces of 32p 
into phosphorylethanolamineE However, relatively few studies have been reported on 
the activity and properties of the enzyme responsible for the reaction. Wittenburg and 
Kornberg 3 showed that  choline kinase (ATP :choline phosphotransferase, EC 2.7.1.32 ) 
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from yeast would also catalyze the formation of phosplmrylettmnolamine, although at 
considerably lower rates. The phosphorylation of both ethanolamine and choline has 
been shown to occur under the same assay condition with a preparation from the 
mollusc Helix lactea 4. Tile properties and conditions for maximum assay of ethanol- 
amine phosphorylation were not studied in either of the above investigations. A more 
detailed study of the phosphorylation of etbanolamine by extracts from Ehrlich 
ascites cells has been performed '~. These studies suggest that  the phosphorylation of 
choline and ethanolamine are catalyzed by separate enzymes and that  tile phosphory- 
lation of ethanolamine is inhibited by choline. 
We have previously shown that  the ability of liver slices to incorporate LI,2-~*C,,]- 
ethanolamine into ethanolamine phosphoglycerides changes significantly during 
functional development of tile liver 6. Tile incorporation by liver slices from 5-day 
fetal rats is about 2o% of the incorporation by adult liver slices. The rate of incorpora- 
tion of iI,2-14C2]ethanolamine into ethanolamine phosphoglyceride increases progres- 
sively with prenatal development so that  by birth 8o~/o of the adult levels are ob- 
tained. In at tempting to explain these developmental changes we are investigating 
the activities and properties of the enzymes that  are associated with tile patllway for 
ethanolamine phosphoglyceride synthesis, in this paper we report the results of 
studies on the activity and properties of ethanolamine phosphokinase from the liver 
of developing rats. 
MATERIALS AND METHODS 
Rats, females I8o-zoo g and sperm positive pregnant, were obtained from 
Holtzman Company, Madison, Vv'isconsin. The beginning of gestation of the pregnant 
animals was determined by Holtzman Company with an accuracy of plus or minus 
12 11. 
The [I,e-14C21ethanolamine, phosphoryllr,2-1~C2]ethanolamine and !y-a2pIATP 
were purchased from New England Nuclear Corporation. Phosphoenolpyruvate, 
pyruvate  kinase (EC 2.7.1.4o), lactate dehydrogenase (EC 1.1.1.27), ADP, ATP, 
CTP, CDP-eholine, phosphorylethanolamine and phosphoryleholine were purchased 
from Sigma. N,N-Dimethylethanolamine, N-methylethanolamine and z-amino-e- 
methyl-I-propanol were purchased from Aldrich Chemical Company. 
Minced liver was homogenized in 4 vol. of o.25 M sucrose. The homogenate was 
centrifuged at IOO ooo × g for I h. The supernatant from the centrifugation contained 
all of tile enzyme activity and was used in all subsequent experiments except where 
stated otherwise. 
Enzyme activity was determined by measuring the production of radioactive 
phosphorylethanolamine from [I,e-14C2~ethanolamine. The incubation mixture con- 
tained, except where altered as noted in specific experiments, eo mM glycylglycine 
buffer (pH 8.5), o.5 mM ethanolamine, o.35 o.4oktCi/ml II,e-14C2? ethanolamine, 3 
mM ATP, 3 mM MgC12 and o.e ml of supernatant (3 4 mg protein). The reaction was 
usually performed in a final volume of I.O ml. The reaction was incubated at 37 °C 
and was stopped by placing the assay tube in boiling water for e rain followed by 
cooling in an ice bath. The protein precipitate was removed by centrifugation and an 
aliquot of the supernatant was passed through a small column (o.5 cm × e cm) of ion 
exchange resin, AG I-X8, ioo zoo mesh, acetate form. The column was washed four 
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times with 5 ml of water and the phosphorylethanolamine was eluted with 3.0 ml of 
i M HC1. The amount of radioactivity in the HC1 eluate was determined in a liquid 
scintillation spectrometer. Either Bray scintillation fluid 7 or Aquasol scintillation 
mixture ~ was employed. Samples of phosphoryl [I,2-14C2]ethanolamine were carried 
through the entire procedure and recoveries of 9O-lOO% were achieved. Zero-time 
blanks were routinely run and were always less than 5% of the assay values. Initially, 
samples of the HC1 eluate were separated by  paper chromatography on Whatman 3 M 
paper with the solvent system ethanol-conc. NH4OH-water,  (61:29:1o, by vol.). The 
majority of the radioactivity (95-97%) migrated similar to standard phosphoryl- 
ethanolamine. The remaining 3-5% was ethanolamine. Phosphorylethanolamine 
production was measured using a paper chromatographic method in addition to an 
ion exchange column method. Both gave identical results. Experiments were per- 
formed where phosphoryl [I,2-14C2jethanolamine was added to the incubation mixture 
in place of the radioactive ethanolamine. The usual concentration of ethanolamine 
was included. There was no evidence for the production of radioactive ethanolamine 
during a I5-min incubation and all of the phosphoryl EI,2-14C2]ethanolamine was 
recovered after the incubation. 
Enzyme activity was measured in some experiments in the presence of an ATP- 
generating system. The reaction mixture consisted of 20 mM glycylglycine (pH 8.5), 
0.5 mM ethanolamine, 0.35 0.40 #Ci/ml [I,2-14C21ethanolamine, 0.8-4. 5 mM ATP, 3 
mM MgC12, 0.4 mM phosphoenolpyruvate, 17 units/ml of pyruvate kinase and liver 
supernatant.  Pyruvate  kinase preparations were dialyzed against 200 vol. of I mM 
EDTA before use in the assay. The reaction was stopped by placing the tubes in 
boiling water. The amount of pyruvate formed during the reaction was determined 
by measuring the decrease of absorbance at 34 ° n m  due to the oxidation of NADH as 
described by Biicher et al. 8. The amount of phosphorylethanolamine formed during 
the reaction was determined as described previously. 
Sephadex G-25 chromatography was performed with a column (2.5 e m ×  33 
cm) that  was packed and eluted with 0.02 M potassium phosphate buffer (pH 7.0). 
Choline was determined by the method described by Reid et al. 9. This procedure 
uses a purified preparation of choline phosphokinase and [?-32P]ATP. The amount 
of [aeP]phosphorylcholine produced is a measurement of the amount of choline 
present in the assay. We used a purified preparation of choline phosphokinase from 
rat  liver. 
The quantitat ive determination of the amount of enzyme inhibition by choline 
was made by plotting ( V  - -  v) /v  versus  the concentration of choline according to the 
transformed Michaelis-Menten equation for competitive inhibition, 
V v Km t fm 
I + 
v SK~ S 
V is the velocity of the reaction in the absence of choline and v the velocity in the 
presence of choline. The choline concentration where ( V  - -  v) /v  = I is the concentra- 
tion that  gives 50% inhibition. 
Protein was determined by the Lowry method TM. 
* A product of New England Nuclear Corporation, Boston, Mass. 
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RESULTS 
Characteristics of the ('nzyme reaction 
The rate of phosphorylethanolamine production, catalyzed by the ioo ooo x ,~, 
supernatant from adult liver, was constant for 2o rain but declined with longer incu- 
bations. The average initial rate of the reaction for I8 separate experiments was 
o.46 ~ o.o4 #mole/min per mg protein. This amounted to a conversion of about o., 7 ,o 
of the ethanolamine to phosphorylethanolamine during the usual I5-min incubation. 
The rate of the reaction catalyzed by fetal liver preparation was constant for 6o rain. 
The pH optimum was found to be 8.5. The activity at pH 8.o and pH 9.o was 
8o°/'0 of the maximal activities. 
The velocity of the reaction was determined at different concentrations of 
ethanolamine. The data gave a linear Lineweaver-Burk plot and an apparent Km of 
z. ~o 4 M was obtained when the ATP and Mg 2+ concentrations were 3.o raM. 
The relationship between Mg 2+ concentration, ATP concentration and enzyme 
activity is shown in Fig. I. These results indicate that the enzyme uses the Mg ATP 
complex as substrate. ATP concentrations that are higher than the Mg 24 concentra- 
tion produce inhibition of the enzyme activity. At Mg 2. concentrations of 1.5 and 
3.o mM the inhibition is apparently caused by free ATP. However, the enzyme activity 
appears also to be inhibited by the Mg ATP complex since the activity with O.o mM 
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Fig. ~. T h e  r e l a t i o n s h i p  be tween  the concen t ra t i ons  o f  A T P  and Mg  ~+ aud  the a c t i v i t y  o f  e thano l -  
amine  phosphokinase ,  Each  va lue  is the  ave rage  of 3 assays.  Each  curve  represen ts  a different  
concen t ra t ion  of Mg 2+ in the  assay.  The Mg 2+ concen t ra t ions  are : A - - A ,  z.5 mM ; I1--11, 3.o mM ; 
O - - O ,  4 .5 raM;  () ' ,  6 . o m M :  V) ~ ,  7.5 raM; :& -,,~, 9 . omM.  E P  e t hano l ami ne  phos- 
phate .  
Enzyme activity was determined in the presence and absence of tile ATP- 
generating system. At ATP concentrations below optimum, higher enzyme activity 
was obtained in the presence of the ATP-generating system, Table I. Maximum 
activity was obtained at 3.o mM ATP and the same activity was obtained in the 
presence and in the absence of the ATP-generating system. Inhibition was still ob- 
served at ATP concentrations higher than the Mg '~+ concentrations. Tile amount of 
pyruvate produced during the reaction, as a measurement of the total production of 
ADP, was determined with lactate dehydrogenase 8. Since more pyruvate was pro- 
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" F A B L E  1 
ETHANOLAMINE PHOSPHOKINASE ACTIVITY IN THE PRESENCE AND ABSENCE OF THE z4tTP-GENERA - 
TING SYSTEM, PHOSPHOENOLPYRUVATE AND PYRUVATE KINASE 
E n z y m e  a c t i v i t y  is e x p r e s s e d  as n m o l e s  of  p h o s p h o r y l e t h a n o l a m i n e  produced in 15 ra in .  P y r u v a t e  
product ion  is reported as the  nmoles  produced in 15 min .  The concentrat ion  of  Mg ~+ w a s  3.o nlM. 
A T P  Ethanolamine phosphohinase activity Pyruvate 
(m2~I) 
VVithout A TP-  With A TP-  With A TP-  
generating generating generating 
system system system 
o o o 5 
0.8 21 32 64 
1.5 28 4 ° 53 
3.0 36 38 67 
3.3 33 35 67 
3.8 23 24 69 
4-5 16 16 69 
duced then predicted from the amount of phosphorylethanolamine produced, some 
ADP was formed by reactions other than the phosphorylation of ethanolamine. 
Inhibition by choline 
Choline inhibits the phosphorylation of ethanolamine catalyzed by liver super- 
natant preparation from fetal, postnatal and adult rats, Table II. Complete inhibition 
is not achieved in any preparation. Fetal preparations appear to be inhibited more 
than the 1-day and adult preparations. In several experiments adult supernatants 
were assayed in the presence of the ATP-generating system and the same amount of 
inhibition was observed. The inhibition with an adult preparation is non-competitive 
with ethanolamine and competitive with ATP, Fig. 2. A K~ for choline of 0.02 mM 
was calculated from the ATP experiment shown in Fig. 2. 
" F A B L E  I l 
THE CHOLINE INHIBITION OF ETHANOLAMINE PHOSPHOKINASE ACTIVITY IN LIVER FROM FETAL, 
NE\VBORN AND ADULT RATS 
A u n i t  o f  e n z y m e  a c t i v i t y  is tha t  a m o u n t  of  e n z y m e  tha t  produces  I nmole  of  phosphory le thano l -  
amine  in 15 min .  E a c h  v a l u e  is the  average of  3 a s says .  T h e  v a l u e s  o f  i n d i v i d u a l  a s s a y s  varied 
f r o m  the  average by  no more  than  l O % .  
Choline Ethanolamine phosphohinase inhibition 
conch 
(raM) --3 days --± day +± day Adult  
Units °/o Units % Units % Units %j, 
Inhibition Inhibition Inhibition Inhibition 
o 24.0 - -  19-4 - -  17.6 - -  39.4 - -  
O.Ol 21.o I I  14.8 18 14. 5 18 39.o o 
o . i o  7.6 68 6.0 69 11.9 32 25.8 32 
0.40 5 .8 76 4-5 77 8.8 5 ° 22.5 43 
1.2o 5 .0 79 5 .2 73 lO.6 60 21.1 46 
i .60 4.9 80 5 .6 71 9.4 53 20.8 47 
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Fig.  2. T h e  i n h i b i t i o n  o f  e t h a n o l a m i n e  p h o s p h o k i n a s e  b y  chol ine .  0 - - 0 ,  3" IO-S M cho l ine ;  
A - - A ,  no  chol ine .  
T A B L E  I I I  
T H E  E F F E C T  O F  S E P H A D E X  T R E A T M E N T  O N  T H E  I N H I B I T I O N  B Y  C H O L I N E  O F  E T H A N O L A M I N E  P H O S -  
P H O K I N A S E  F R O M  A D U L T  L I V E R  
See T a b l e  I I  for  e x p l a n a t i o n s .  
Choline Ethanolamine phosphokinase activity 
£ o n c ~  
(raM) Before Sephadex After Sephadex 
Units % Units % 
Inhibition Inhibition 
o 39 - -  27 - -  
o .o i  38 o 23 15 
o . i  26 32 8 72 
o.4 23 43 5 83 
1.2 21 46 - -  - -  
1.6 21 47 5 82 
The maximal amount of choline inhibition that  is observed with an adult 
preparation increases after passage of the preparation through a Sephadex 0-25 
column, Table I I I .  This also occurs with fetal preparations, Table IV. This phenomena 
is apparently caused by the removal of low molecular weight materials from the 
preparation since dialysis of supernatant against either 2o mM phosphate buffer 
(pH 7.o) or against distilled water produces the same result as Sephadex treatment.  
Furthermore, dilution of the supernatant with 2o mM phosphate buffer or with 
o.25 M sucrose does not cause a change in choline inhibition, nor does concentration 
of the diluted preparation by lyophilization. 
The ability of compounds that  are structurally or metabolically related to 
choline to inhibit the phosphorylation of ethanolamine was determined, Table V. A 
Sephadex-treated supernatant from adult liver was utilized. Betaine and cytidine-di- 
phosphocholine had no inhibitory activity at the concentration employed. Phosphoryl- 
Biochim. Biophys. Acta, 276 (1972) 143 -154  
E T H A N O L A M I N E  P H O S P H O K I N A S E  149 
T A B L E  I V  
T H E  E F F E C T  OF S E P H A D E X  T R E A T M E N T  ON T H E  I N H I B I T I O N  BY" C H O L I N E  OF E T H A N O L A M I N E  P H O S -  
P H O K I N A S E  F R O M  F E T A L  L I V E R  
A u n i t  o f  a c t i v i t y  is de f ined  in T a b l e  I I .  E a c h  v a l u e  is t h e  a v e r a g e  o f  3 a s says .  
Choline Ethanolamine phosphokinase activity 
c o h e n  
(mM) --3 days --r. day 
Before Sephadex After Sephadex Before Sephadex After Sephadex 
Units % Units % Units % Units % 
Inhibition Inhibition Inhibition Inhibition 
o 19.4 - -  12.9 24 - -  20.6 - -  
o . o i  14.8 18 lO.6 18 21.o I I  21. 3 o 
o . i  6.0 69 1.3 9o 7.6 68 2.6 87 
° .4  4.5 77 o IOO 5 .8 76 0.3 99 
1.2 5 .2 73 0.3 97 5 .0 79 o IOO 
1.6 5.6 71 o IOO 4.9 79 o i o o  
T A B L E  V 
THE SPECIFICITY OF THE INHIBITION OF ETHANOLAMINE PHOSPHOKINASE 
All c o m p o u n d s  w e r e  a d d e d  to  t h e  s t a n d a r d  a s s a y  a t  a final c o n c e n t r a t i o n  o f  o. i m M  . T h e  S e p h a d e x -  
t r e a t e d  s u p e r n a t a n t  f r o m  a d u l t  l i v e r  w a s  u sed  as a sou rce  o f  e t h a n o l a m i n e  p h o s p h o k i n a s e .  
Compound % Inhibition 
Chol ine  81 
P h o s p h o r y l c h o l i n e  29 
C y t i d i n e d i p h o s p h o c h o l i n e  o 
B e t a i n e  o 
P h o s p h o r y l e t h a n o l a m i n e  8 
D i m e t h y l e t h a n o l a m i n e  79 
M o n o m e t h y l e t h a n o l a m i n e  34 
2 - A m i n o - 2 - m e t h y l p r o p a n o l  21 
choline has some inhibitory activity while phosphorylethanolamine gave only slight, 
if any, inhibition. However, dimethylethanolamine was equally as inhibitory as 
choline, while monomethylethanolamine was considerably less inhibitory. 2-Amino-2- 
rnethylpropanol, a compound that  has been shown to inhibit the incorporation of 
[I,2-14C21ethanolamine into ethanolamine phosphoglycerides 11, also inhibits ethanol- 
amine phosphokinase. However, the amount of inhibition is much less than that  ob- 
tained with choline. 
Ethanolamine phosphokinase activity during development 
The activity of ethanolamine phosphokinase in the liver from fetal and young 
rats was compared to the activity in the livers from adult female rats, Fig. 3- The 
activity is expressed per g wet liver, per total mg of protein and per mg of protein in 
the IOO ooo × g supernatant.  The same relative developmental pattern is obtained 
regardless of how the activity is expressed. Low activity is observed in liver from 
--5-day-old fetuses. The activi ty increases about 2-fold from --5 days to --2 days. A 
large drop in activity occurs between birth and I day after birth. The activity 
Biochim. Biophys. Acta, 276 (1972) 1 4 3 -1 5 4  
I ~ 0  P . A .  WEINHOLD, V. B. RETHY 
~ 0  
Q 
'~ I00 
,o / 'f 
' - ;  . . . .  ; . . . .  ; . . . .  6 . . . .  , ;  . . . .  2'o . . . .  ~ . . . .  ~ . . . .  ; ~  . . . .  , ,o 
A G E  ( d o y s )  
Fig. 3. Ethanolamine  phosphokinase activity (luring the developnlent of the liver, lLach wdue is 
the average of 3-6 separate experinlents.  Exper iments  with fetal ra ts  involved the combinat ion of 
all livers from the fetuses from a single p regnan t  rat. The exper iments  with young rats  involved 
the combinat ion of the livers from 3 rats  from a single litter. All assays were done in triplicate and 
averaged. The data  is represented as : act ivi ty/g fresh liver, (O- -O)  ; act ivi ty/rag of total protein 
( ~ - - . ~ ) ;  and activity/rag of IOOOOO x g supe rna tan t  protein ( © - - Q ) .  The bar  above or below 
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Fig. 4. Rthanolamine phosphokinase  activity at  different concentrat ions of supe rna tan t  protein. 
Port ions of the same superna tan t  prepara t ions  were assayed before passage th rough  Sephadex 
G-25 (O- -Q)  and after Sephadex G-25 t r ea tmen t  ( O - - @ ) .  A, --4 days;  B, i day; C, [ day;  
D, adult. EP  ~ e thanolamine phospha te .  
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increases at a rather uniform rate from I day to a peak value 2oo% of the adult at 
14 days. The activity begins to drop toward adult levels at 33-34 days. The differ- 
ences between the values expressed on a wet weight basis and the values expressed 
on a tissue protein basis are primarily due to differences in the amount of protein per 
weight of tissue. 
The inhibition of ethanolamine phosphokinase by an endogenous inhibitor 
A non-linear relationship between the amount of phosphorylethanolamine 
produced and the amount of supernatant used in the assay was observed, Fig. 4. 
This suggests that  the IOO ooo × g supernatant preparations contain an inhibitor of 
ethanolamine phosphokinase. The degree of inhibition of enzyme activity varied with 
the age of the animal. The amount of inhibition was slight in the adult preparations, 
Fig. 4D, but was considerable in - -4-day fetal and 1-day-old preparations, Figs 4 A 
and 4C. This inhibition could be eliminated by passage of the supernatant preparation 
through a Sephadex G-25 column, Fig. 4, or by dialysis. 
When the enzyme activity was determined on Sephadex-treated preparations, a 
different developmental pat tern of enzyme activity was obtained, Fig. 5. The activity 
was now near adult levels at - -4  days and increased above adult levels as development 
progressed. The drop in activity I day after birth that  was observed with untreated 
preparations did not occur but instead the enzyme activity continued to rise after birth. 
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Fig. 5. ] 'he developmental change in ethanolamine phosphokinase tha t  was determined with 
Sephadcx G-25-treated preparations. The activity was expressed as units/g of fresh liver. 
Characteristics of the endogenous inhibitor 
A crude preparation of the inhibitor was obtained by passing liver supernatant 
from 1-day-old rats through a column of Sephadex G-25. The fractions from the 
column that  were obtained between the last measurable amount of protein and the 
total column volume were combined and evaporated under vacuum. These prepara- 
tions had considerable inhibitory activity. Equally as active preparations were ob- 
tained by dialysis of supernatant against distilled water and evaporation of the dialy- 
sate. The inhibition by such preparations is competitive with ATP (Fig. 6). 
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Fig. 6. The inhibition of ethanolamine phosphokinase by the endogenous inhibition: O, 5 ttl; 
I ,  2.5/d; A, no inhibitor. 
The chromatographic behavior of the inhibitor was investigated. The crude 
preparation was chromatographed on Whatman 3 M paper. The chromatograms were 
sectioned and each section was extracted with o.2 M HC1. The inhibitory activity 
moved identically with standard choline in the solvent systems 95°(~ ethanol conc. 
NH4OH (95:5, v/v) and n-propanol-water (7:3, v/v). 
The amount of choline was determined in a preparation that was obtained by 
dialysis of adult supernatant. This preparation had o.46/,mole of choline per ml. Tile 
amount of inhibition that was obtained with this preparation was compared with the 
inhibition obtained with choline on the same enzyme preparation. By referring to the 
(V  - -  v)/v versz~s I plot for choline inhibition we predicted from the choline concentra- 
tion of the inhibitor preparation that 2/*1 would give 49% inhibition. We actually 
obtained 39% inhibition. 
DISCUSSION 
The conditions for maximal activity of ethanolamine phosphokinase from rat 
liver have been determined. The activity is recovered in the supernatant fraction 
after centrifugation at IOO ooo x g for 6o min. A similar distribution of ethanolamine 
phosphokinase in Ehrlich ascites cells has been reported 5. The relationship of enzyme 
activity with ATP and Mg 2+ concentration indicates that the Mg-ATP complex is the 
substrate for the reaction and that ATP causes inhibition. The enzyme is not inhibited 
by ADP under our assay conditions since the same maximal activity and the same 
amount of inhibition with ATP was obtained with or without the ATP-generating 
system. The apparent Km for ethanolamine is similar to the apparent K m  that was 
reported for preparations from Ehrlich ascites cells 5. 
Sung and Johnstone '~ reported that ethanolamine phosphokinase activity in 
Ehrlich ascites ceils was inhibited by choline. Ethanolamine phosphokinase activity 
in the spleen, kidney and brain of mice was also inhibited by choline. However, they 
found no inhibition by choline with enzyme preparations from mouse liver. We find 
that ethanolamine phosphokinase from rat liver is strongly inhibited by choline. 
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Furthermore, the inhibition is non-competitive with ethanolamine and is competitive 
with ATP. Thus, the inhibition is apparently not a result of competition between the 
structurally similar compounds, ethanolamine and choline, for a site on the enzyme. 
It  is conceivable that choline is causing an apparent inhibition of ethanolamine 
phosphorylation through depletion of the ATP concentration and/or the production 
of ADP by choline phosphokinase activity. These possibilities are excluded by the 
observations that choline still inhibited ethanolamine phosphokinase when the assay 
was performed in the presence of the ATP-generating system. An interesting aspect 
of the choline inhibition is the observation that ethanolamine phosphokinase activity 
in the supernatant can not be completely inhibited by choline. This phenomenon was 
apparently also observed by Sung and Johnstone '~ with preparations from mouse 
spleen and kidney since they obtained the same amount of inhibition with o.o 5 and 
o.5 mM choline. Our observations that Sephadex G-25 treatment or dialysis increases 
the amount of maximal inhibition by choline suggests that the susceptability of 
ethanolamine phosphokinase to choline inhibition may be altered by the removal of 
some low molecular weight substances. One possibility is that ethanolamine phospho- 
kinase exists in the supernatant in two forms. One form is inhibited by choline while 
the other is not inhibited. The removal of substances by either Sephadex G-25 treat- 
ment or by dialysis converts the non-inhibited form to the inhibited form. This 
phenomenon is under further investigation with a purified preparation of ethanolamine 
phosphokinase. 
The ioo ooo × g supernatant fraction at all ages contains an endogenous 
inhibitor of ethanolamine phosphokinase. The amount of inhibition changes with 
development and therefore affects the developmental pattern of apparent enzyme 
activity. All the evidence indicates that the endogenous inhibitor is choline. The 
inhibition by the endogenous inhibitor is competitive with ATP, as is the inhibition 
by choline. The inhibitory activity migrates on paper the same as choline in two 
solvent systems. Furthermore, the amount of inhibition that is obtained with a 
preparation of the endogenous inhibitor is correlated with the amount of choline in 
the preparation. 
The inhibition by choline of ethanolamine phosphokinase may be an example of 
feedback control. Choline is synthesized in the liver by the methylation of ethanol- 
amine phosphoglycerides lz. Thus, a pathway for choline synthesis begins with the 
phosphorylation of ethanolamine by ethanolamine phosphokinase and proceeds 
through the synthesis of ethanolamine phosphoglycerides. Therefore, the concentra- 
tions of choline, the final product of the pathway, could regulate choline synthesis by 
altering the activity of ethanolamine phosphokinase. 
The developmental pattern of ethanolamine phosphokinase in some ways is 
similar to the development pattern that was observed for the incorporation by liver 
slices of [I,2-14C2]ethanolamine into ethanolamine phosphoglycerides 6. Both activities 
are low in --5-day fetal and increase with prenatal development. However, the ability 
of slices to incorporate [i,2-14C2]ethanolamine into ethanolamine phosphoglycerides is 
2o% of the adult at --5 days, while the ethanolamine phosphokinase activity is 5o% 
of the adult levels. The ethanolamine phosphokinase activity reaches adult levels 
before birth and increases to two times adult levels by 14 days after birth, while the 
incorporation of [I,2-14C2~ethanolamine by liver slices reaches 8o% of adult values 
before birth and does not increase above adult levels in the young rat. Thus, the 
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developmental changes in the activity of the total pathway for the incorporation of 
ethanolamine into ethanolamine phosphoglycerides, as measured previously with 
liver slices, is not solely due to changes in ethanolamine phosphokinase activity, 
particularly in the postnatal period. 
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